| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.4M | — |
| R&D Expense | $210.4M | +25.6% |
| SG&A Expense | $68.9M | +48.0% |
| Operating Income | -$279.3M | -30.5% |
| Pre-tax Income | -$238.4M | -30.5% |
| Income Tax | -$4.1M | -1300.3% |
| Net Income | -$234.3M | -28.5% |
| EPS (Basic) | -$3.01 | -10.3% |
| EPS (Diluted) | -$3.01 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $142.7M | -4.0% |
| Short-term Investments | $484.2M | -1.1% |
| Accounts Receivable | $1.5M | +68.1% |
| Current Assets | $635.3M | -1.5% |
| Total Assets | $798.1M | -17.3% |
| Current Liabilities | $35.6M | +30.5% |
| Total Liabilities | $43.2M | +17.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$181.4M | -24.8% |
| Capital Expenditures | $3.1M | -45.3% |
| Investing Cash Flow | $165.0M | +240.8% |
| Financing Cash Flow | $12.1M | -96.6% |
| Free Cash Flow | -$184.5M | -22.2% |
| -10.3% |
| Stockholders' Equity |
| $754.9M |
| -18.6% |